| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
to the development of renal fibrosis
1 Departments of Internal Medicine, 2 Cell Biology and Physiology, and 3 Pathology, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri 63110-1092
Angiotensin II upregulates tumor
necrosis factor-
(TNF-) in the rat kidney with unilateral
ureteral obstruction (UUO). In a mouse model of UUO, we found that
tubulointerstitial fibrosis is blunted when the TNF- receptor,
TNFR1, is functionally knocked out. In this study, we used mutant mice
with UUO in which the angiotensin II receptor AT1a or the
TNF- receptors TNFR1 and TNFR2 were knocked out to elucidate
interactions between the two systems. The contribution of both systems
to renal fibrosis was assessed by treating TNFR1/TNFR2-double knockout
(KO) mice with an angiotensin-converting enzyme inhibitor, enalapril.
The increased interstitial volume (Vvint) in the C57BI/6
wild-type mouse was decreased in the AT1a KO from 32.8 ± 4.0 to 21.0 ± 3.7% (P < 0.005) or in the
TNFR1/TNFR2 KO to 22.3 ± 2.1% (P < 0.005). The Vvint of the TNFR1/TNFR2 KO was further
decreased to 15.2 ± 3.7% (P < 0.01) by
enalapril compared with no treatment. The induction of TNF- mRNA and
transforming growth factor-
1 (TGF-1) mRNA in the kidney with UUO
was significantly blunted in the AT1a or TNFR1/TNFR2 KO
mice compared with the wild-type mice. Treatment of the TNFR1/TNFR2 KO
mouse with enalapril reduced both TNF- and TGF-1 mRNA and their
proteins to near normal levels. Also, -smooth muscle actin
expression and myofibroblast proliferation were significantly inhibited
in the AT1a or TNFR1/TNFR2 KO mice, and they were further
inhibited in enalapril-treated TNFR1/TNFR2 KO mice. Incapacitating
the angiotensin II or the TNF- systems individually leads to partial
blunting of fibrosis. Incapacitating both systems, by using a
combination of genetic and pharmacological means, further inhibited
interstitial fibrosis and tubule atrophy in obstructive nephropathy.
interstitial volume; myofibroblast; tubulointerstitial fibrosis
This article has been cited by other articles:
|
|
 |
|
  P. D. Metcalfe, J. A. Leslie, M. T. Campbell, D. R. Meldrum, K. L. Hile, and K. K. Meldrum Testosterone exacerbates obstructive renal injury by stimulating TNF-{alpha} production and increasing proapoptotic and profibrotic signaling Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E435 - E443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Gardner, S. M. Turner, A. Bautista, G. Lindwall, M. Awada, and M. K. Hellerstein Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1695 - G1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mizobuchi, J. Morrissey, J. L. Finch, D. R. Martin, H. Liapis, T. Akizawa, and E. Slatopolsky Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1796 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Wahba and R. H. Mak Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Meldrum, R. Misseri, P. Metcalfe, C. A. Dinarello, K. L. Hile, and D. R. Meldrum TNF-{alpha} neutralization ameliorates obstruction-induced renal fibrosis and dysfunction Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1456 - R1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. O. Chen, M. H. Park, M. S. Forbes, B. A. Thornhill, S. C. Kiley, K. H. Yoo, and R. L. Chevalier Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat Am J Physiol Renal Physiol, March 1, 2007; 292(3): F946 - F955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. I. Abdullah, P. L. Pedraza, S. Hao, K. D. Rodland, J. C. McGiff, and N. R. Ferreri NFAT regulates calcium-sensing receptor-mediated TNF production Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1110 - F1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Elmarakby, J. E. Quigley, D. M. Pollock, and J. D. Imig Tumor Necrosis Factor {alpha} Blockade Increases Renal Cyp2c23 Expression and Slows the Progression of Renal Damage in Salt-Sensitive Hypertension Hypertension, March 1, 2006; 47(3): 557 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chatziantoniou and J.-C. Dussaule Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol, August 1, 2005; 289(2): F227 - F234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Misseri, D. R. Meldrum, C. A. Dinarello, P. Dagher, K. L. Hile, R. C. Rink, and K. K. Meldrum TNF-{alpha} mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling Am J Physiol Renal Physiol, February 1, 2005; 288(2): F406 - F411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stambe, R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreiner, and D. J. Nikolic-Paterson The Role of p38{alpha} Mitogen-Activated Protein Kinase Activation in Renal Fibrosis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 370 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lasaitiene, Y. Chen, G. Guron, N. Marcussen, A. Tarkowski, E. Telemo, and P. Friberg Perturbed medullary tubulogenesis in neonatal rat exposed to renin-angiotensin system inhibition Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2534 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. T. Yu Progression of Chronic Renal Failure Arch Intern Med, June 23, 2003; 163(12): 1417 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Klahr and J. Morrissey Obstructive nephropathy and renal fibrosis Am J Physiol Renal Physiol, November 1, 2002; 283(5): F861 - F875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, C. Dai, and Y. Liu Hepatocyte Growth Factor Gene Therapy and Angiotensin II Blockade Synergistically Attenuate Renal Interstitial Fibrosis in Mice J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2464 - 2477. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
